The TREFOIL Concept 5 Year Clinical Investigation
Primary Purpose
Edentulous or Failing Dentition Mandible
Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
TREFOIL concept
Sponsored by
About this trial
This is an interventional treatment trial for Edentulous or Failing Dentition Mandible
Eligibility Criteria
Inclusion Criteria:
- Obtained informed consent from the subject.
- The subject is at least 18 years of age (passed cessation of growth) and not older than 80 years.
- The subject is in such a physical and mental condition that a 5-year follow-up period can be carried out without foreseeable problems.
- The subject fulfills the prerequisite that a harmonic, stable occlusal relationship can be achieved with opposing natural teeth resp. fixed or removable opposing dentition (tooth or implant based) or soft tissue born denture.
- The subject is willing and able to comply with all study related procedures (such as exercising oral hygiene and attending all follow-up procedures).
- The subject is compliant with good oral hygiene.
- The subject has an edentulous mandible or failing mandibular dentition providing sufficient bone in the interforaminal where a fixed restoration on three (3) implants is regarded as an appropriate treatment solution.
- The subject has an osseous architecture enough to receive three implants with a length of at least 11.5 mm and a diameter of 5 mm in the interforaminal (e.g. jaw volume B, C or D; inter foramina distance at least 20 mm; buccal/lingual width at least 6-7 mm, vertical height after leveling bone sufficient to receive an implant of at least 11.5 mm length).
- The subject has a jaw curvature that fits to the prefabricated framework design.
- Implants will be placed in healed or extraction sites (clinical stability has to be ensured).
- The implant sites are free from infection and extraction remnants.
- The subjects as well as the implant sites fulfill the criteria for early loading.
Smokers that have reduced their consumption may be included after a certain test phase (e.g. test phase for reduction from 2 to 1 packages of cigarettes should be at least 6 months).
Class II inter-jaw relation patients are not an exclusion criteria per se. Based on the individual judgment of the clinician those patients may be treated.
Subject inclusion criteria at time of surgery
- After bone leveling sufficient mandible bone volume in the interforaminal present for three (3) implants with a length of at least 11.5 mm and a diameter of 5 mm.
- After bone leveling the jaw curvature does fit to the prefabricated framework.
- The implant sites are free from infection and extraction remnants.
- The subject as well as the implant sites fulfill the criteria for early loading.
Exclusion Criteria:
- The subject is not able to give her/his informed consent of participating.
- Health conditions, which do not permit the surgical (including anesthesia) or restorative procedure.
- Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or history.
- Any disorders in the planned implant area such as previous tumors, chronic bone disease or previous irradiation.
- Alcohol or drug abuse as noted in subject records or in subject history.
- Smoking of more than 1 package of cigarettes per day (> 20 cigarettes or equivalent).
- Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake or A1c level above 8%.
- Bisphosphonate therapy - based on individual judgment of the clinician (if intravenously administered or too high oral doses recently before surgery and during follow-up period).
- Pathologic occlusion, e.g. severe bruxism or other destructive habits.
- Lack of opposing dentition or unstable occlusion.
- Ongoing infections, endodontic or periodontal problems in opposing teeth or implants.
- Subject shows an unacceptable oral hygiene.
- Subject has allergic or adverse reactions to the restorative material.
Sites / Locations
- Dr. Higuchi &Skinner
- Branemark Centre
- Clinica Rosenberg
- University of Verona
- Instituto Davó, Hospital Medimar Internacional
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Treatment with Trefoil concept
Arm Description
Treatment
Outcomes
Primary Outcome Measures
Cumulative survival rates for the implants
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02940353
Brief Title
The TREFOIL Concept 5 Year Clinical Investigation
Official Title
The TREFOIL Concept: A Clinical Investigation in the Mandible on 3 Implants With a Fixed Prefabricated Framework
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
April 2016 (undefined)
Primary Completion Date
June 2022 (Actual)
Study Completion Date
June 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nobel Biocare
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Prospective, single cohort, multi-center study evaluating the TREFOIL concept for the treatment of edentulous or patients with failing mandibular dentition over 5 years. 90 patients (15 per centre) will be included. The subject population is at least 18 years old, in need of an implant restored full prosthesis providing sufficient bone in the interforaminal where a fixed restoration on three implants is regarded as an appropriate treatment solution. The components are TREFOIL treatment concept (implants and framework).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Edentulous or Failing Dentition Mandible
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
110 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Treatment with Trefoil concept
Arm Type
Other
Arm Description
Treatment
Intervention Type
Device
Intervention Name(s)
TREFOIL concept
Primary Outcome Measure Information:
Title
Cumulative survival rates for the implants
Time Frame
5 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Obtained informed consent from the subject.
The subject is at least 18 years of age (passed cessation of growth) and not older than 80 years.
The subject is in such a physical and mental condition that a 5-year follow-up period can be carried out without foreseeable problems.
The subject fulfills the prerequisite that a harmonic, stable occlusal relationship can be achieved with opposing natural teeth resp. fixed or removable opposing dentition (tooth or implant based) or soft tissue born denture.
The subject is willing and able to comply with all study related procedures (such as exercising oral hygiene and attending all follow-up procedures).
The subject is compliant with good oral hygiene.
The subject has an edentulous mandible or failing mandibular dentition providing sufficient bone in the interforaminal where a fixed restoration on three (3) implants is regarded as an appropriate treatment solution.
The subject has an osseous architecture enough to receive three implants with a length of at least 11.5 mm and a diameter of 5 mm in the interforaminal (e.g. jaw volume B, C or D; inter foramina distance at least 20 mm; buccal/lingual width at least 6-7 mm, vertical height after leveling bone sufficient to receive an implant of at least 11.5 mm length).
The subject has a jaw curvature that fits to the prefabricated framework design.
Implants will be placed in healed or extraction sites (clinical stability has to be ensured).
The implant sites are free from infection and extraction remnants.
The subjects as well as the implant sites fulfill the criteria for early loading.
Smokers that have reduced their consumption may be included after a certain test phase (e.g. test phase for reduction from 2 to 1 packages of cigarettes should be at least 6 months).
Class II inter-jaw relation patients are not an exclusion criteria per se. Based on the individual judgment of the clinician those patients may be treated.
Subject inclusion criteria at time of surgery
After bone leveling sufficient mandible bone volume in the interforaminal present for three (3) implants with a length of at least 11.5 mm and a diameter of 5 mm.
After bone leveling the jaw curvature does fit to the prefabricated framework.
The implant sites are free from infection and extraction remnants.
The subject as well as the implant sites fulfill the criteria for early loading.
Exclusion Criteria:
The subject is not able to give her/his informed consent of participating.
Health conditions, which do not permit the surgical (including anesthesia) or restorative procedure.
Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or history.
Any disorders in the planned implant area such as previous tumors, chronic bone disease or previous irradiation.
Alcohol or drug abuse as noted in subject records or in subject history.
Smoking of more than 1 package of cigarettes per day (> 20 cigarettes or equivalent).
Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake or A1c level above 8%.
Bisphosphonate therapy - based on individual judgment of the clinician (if intravenously administered or too high oral doses recently before surgery and during follow-up period).
Pathologic occlusion, e.g. severe bruxism or other destructive habits.
Lack of opposing dentition or unstable occlusion.
Ongoing infections, endodontic or periodontal problems in opposing teeth or implants.
Subject shows an unacceptable oral hygiene.
Subject has allergic or adverse reactions to the restorative material.
Facility Information:
Facility Name
Dr. Higuchi &Skinner
City
Spokane
State/Province
Washington
ZIP/Postal Code
99216-1077
Country
United States
Facility Name
Branemark Centre
City
Perth
State/Province
Western Australia
ZIP/Postal Code
6005
Country
Australia
Facility Name
Clinica Rosenberg
City
Santiago
State/Province
Santiago De Chile
ZIP/Postal Code
10373
Country
Chile
Facility Name
University of Verona
City
Verona
ZIP/Postal Code
37131
Country
Italy
Facility Name
Instituto Davó, Hospital Medimar Internacional
City
Alicante
ZIP/Postal Code
03016
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
The TREFOIL Concept 5 Year Clinical Investigation
We'll reach out to this number within 24 hrs